These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27325342)

  • 1. A Systematic Review of the Cost-Effectiveness of Long-Term Mechanical Circulatory Support.
    Nunes AJ; MacArthur RG; Kim D; Singh G; Buchholz H; Chatterley P; Klarenbach SW
    Value Health; 2016 Jun; 19(4):494-504. PubMed ID: 27325342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(3):1-60. PubMed ID: 27026798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic Evaluation of Left Ventricular Assist Devices for Patients With End Stage Heart Failure Who Are Ineligible for Cardiac Transplantation.
    Chew DS; Manns B; Miller RJH; Sharma N; Exner DV
    Can J Cardiol; 2017 Oct; 33(10):1283-1291. PubMed ID: 28941608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.
    Rogers JG; Bostic RR; Tong KB; Adamson R; Russo M; Slaughter MS
    Circ Heart Fail; 2012 Jan; 5(1):10-6. PubMed ID: 22052901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of the implantable HeartMate II left ventricular assist device for patients awaiting heart transplantation.
    Moreno SG; Novielli N; Cooper NJ
    J Heart Lung Transplant; 2012 May; 31(5):450-8. PubMed ID: 22115674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure.
    Long EF; Swain GW; Mangi AA
    Circ Heart Fail; 2014 May; 7(3):470-8. PubMed ID: 24563450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and cost-effectiveness of left ventricular assist devices as a bridge to heart transplantation for people with end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt JL; Royle P; Bryant J
    Eur Heart J; 2006 Dec; 27(24):2929-38. PubMed ID: 16603577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of ventricular assist device therapy as a bridge to transplantation compared with nonbridged cardiac recipients.
    Alba AC; Alba LF; Delgado DH; Rao V; Ross HJ; Goeree R
    Circulation; 2013 Jun; 127(24):2424-35. PubMed ID: 23697907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: A United Kingdom perspective.
    Lim HS; Shaw S; Carter AW; Jayawardana S; Mossialos E; Mehra MR
    J Heart Lung Transplant; 2022 Feb; 41(2):174-186. PubMed ID: 34922821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service bridge-to-transplant program for patients with heart failure.
    Pulikottil-Jacob R; Suri G; Connock M; Kandala NB; Sutcliffe P; Maheswaran H; Banner NR; Clarke A
    J Heart Lung Transplant; 2014 Apr; 33(4):350-8. PubMed ID: 24582838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Economic aspects of implementation of the mechanical heart, "HeartMate"].
    Kolbye A; Sander Jensen KM; Aldershvile J; Hansen PB; Kjersem AM; Nielsen KS; Olsen PS; Rasmussen B; Vogelsang G
    Ugeskr Laeger; 2000 Jun; 162(26):3722-5. PubMed ID: 10925632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness of Ventricular Assist Device Destination Therapy for Advanced Heart Failure in Duchenne Muscular Dystrophy.
    Magnetta DA; Kang J; Wearden PD; Smith KJ; Feingold B
    Pediatr Cardiol; 2018 Aug; 39(6):1242-1248. PubMed ID: 29774392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness of Left Ventricular Assist Devices in Ambulatory Patients With Advanced Heart Failure.
    Baras Shreibati J; Goldhaber-Fiebert JD; Banerjee D; Owens DK; Hlatky MA
    JACC Heart Fail; 2017 Feb; 5(2):110-119. PubMed ID: 28017351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of left ventricular-assist devices in end-stage heart failure.
    Hutchinson J; Scott DA; Clegg AJ; Loveman E; Royle P; Bryant J; Colquitt JL
    Expert Rev Cardiovasc Ther; 2008 Feb; 6(2):175-85. PubMed ID: 18248272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of continuous-flow left ventricular assist devices.
    Neyt M; Van den Bruel A; Smit Y; De Jonge N; Erasmus M; Van Dijk D; Vlayen J
    Int J Technol Assess Health Care; 2013 Jul; 29(3):254-60. PubMed ID: 23763844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Special report: cost-effectiveness of left-ventricular assist devices as destination therapy for end-stage heart failure.
    Technol Eval Cent Assess Program Exec Summ; 2004 Apr; 19(2):1. PubMed ID: 15314825
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-utility analysis of direct ventricular assist device vs double bridges to heart transplantation in patients with refractory heart failure.
    Chang HH; Chen PL; Chen IM; Kuo TT; Weng ZC; Huang PJ; Wu NY; Cheng CL
    Clin Transplant; 2017 Dec; 31(12):. PubMed ID: 28944511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heart transplantation and long-term lvad support cost-effectiveness model].
    Szentmihályi I; Barabás JI; Bali Á; Kapus G; Tamás C; Sax B; Németh E; Pólos M; Daróczi L; Kőszegi A; Cao C; Benke K; Kovács PB; Fazekas L; Szabolcs Z; Merkely B; Hartyánszky I
    Magy Seb; 2016 Dec; 69(4):186-193. PubMed ID: 27991023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of 1-year left ventricular assist device destination therapy in chronic heart failure: a comparison with heart transplantation.
    Droogne W; Jacobs S; Van den Bossche K; Verhoeven J; Bostic RR; Vanhaecke J; Van Cleemput J; Rega F; Meyns B
    Acta Clin Belg; 2014 Jun; 69(3):165-70. PubMed ID: 24820923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.